Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03976414 · ClinicalTrials.gov registry record
Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 260
- Enrollment target
NCT03976414: Completed study, sponsored by University of Wisconsin, Madison.
NCT03976414 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03976414 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
The objective of this study is to (1) use participatory ergonomics to adapt and in-person 3-session intervention: Mind Over Matter: Healthy Bowels, Healthy Bladder (MOM) to an electronic program (eMOM), and to (2) compare and characterize eMOM's reach when marketed via community agencies versus Facebook advertising and to collect qualitative and quantitative data about effectiveness and uptake of key behaviors using electronic surveys and phone interviews. The study will also collect information from community agencies that might implement eMOM about its perceived value and their willingness and capacity to implement such a program.
Primary Outcome
Global perception of improvement (GPI) is a tool for Global Rating of Patient Satisfaction and Perceptions of Improvement. Question asked: Overall, do you feel that you are? Response can be chosen from the options: Much Better, Better, About the same, Worse, Much worse
Interventions
- OTHER eMOM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2020-05-31 |
What the finished NCT03976414 record still lists
NCT03976414 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which eMOM is the first listed.
NCT03976414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03976414 about?
NCT03976414 is a clinical study titled "Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program". The objective of this study is to (1) use participatory ergonomics to adapt and in-person 3-session intervention: Mind Over Matter: Healthy Bowels, Healthy Bladder (MOM) to an electronic program (eMOM), and to (2) compare and characterize eMOM's reach when marketed via community agencies versus Face...
What is the current status of trial NCT03976414?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2019-06-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03976414?
The interventions under investigation include: eMOM (OTHER).
Who is sponsoring clinical trial NCT03976414?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI